Disruption of the ATP8A2 gene in a patient with a t(10;13) de novo balanced translocation and a severe neurological phenotype.
Mental retardation is a frequent condition that is clinically and genetically highly heterogeneous. One of the strategies used to identify new causative genes is to take advantage of balanced chromosomal rearrangements in affected patients. We characterized a de novo t(10;13) balanced translocation in a patient with severe mental retardation and major hypotonia. We found that the balanced translocation is molecularly balanced. The translocation breakpoint disrupts the coding sequence of a single gene, called ATP8A2. The ATP8A2 gene is not ubiquitously expressed, but it is highly expressed in the brain. In situ hybridization performed in mouse embryos at different stages of development with the mouse homologue confirms this observation. A total of 38 patients with a similar phenotype were screened for mutations in the ATP8A2 gene but no mutations were found. The balanced translocation identified in this patient disrupts a single candidate gene highly expressed in the brain. Although this chromosomal rearrangement could be the cause of the severe phenotype of the patient, we were not able to identify additional cases. Extensive screening in the mentally retarded population will be needed to determine if ATP8A2 haploinsufficiency or dysfunction causes a neurological phenotype in humans.
Cacciagli
Pierre
P
Département de Génétique Médicale, Hôpital d'Enfants de La Timone, Marseille, France.
Haddad
Marie-Reine
MR
Mignon-Ravix
Cécile
C
El-Waly
Bilal
B
Moncla
Anne
A
Missirian
Chantal
C
Chabrol
Brigitte
B
Villard
Laurent
L
D000251:Adenosine Triphosphatases / Q000235:genetics* / Q000378:metabolism; D000818:Animals; D002675:Child, Preschool; D002879:Chromosomes, Human, Pair 10 / Q000235:genetics*; D002882:Chromosomes, Human, Pair 13 / Q000235:genetics*; D005260:Female; D020869:Gene Expression Profiling; D005820:Genetic Testing; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D051379:Mice; D009154:Mutation / Q000235:genetics; D009422:Nervous System Diseases / Q000235:genetics*; D010641:Phenotype; D049294:Phospholipid Transfer Proteins / Q000235:genetics* / Q000378:metabolism; D011247:Pregnancy; D014178:Translocation, Genetic / Q000235:genetics*
D049294:Phospholipid Transfer Proteins; D000251:Adenosine Triphosphatases; C545445:ATP8A2 protein, human